AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Phibro Animal HealthPhathom PharmaceuticalsEndo InternationalSupernus PharmaceuticalsCannTrust
SymbolNASDAQ:PAHCNASDAQ:PHATNASDAQ:ENDPNASDAQ:SUPNOTCMKTS:CNTTF
Price Information
Current Price$25.67$44.00$4.00$23.76N/A
52 Week RangeHoldBuyHoldHoldN/A
Beat the Market™ Rank
Overall Score1.81.91.51.81.1
Analysis Score1.01.43.13.20.0
Community Score2.22.62.63.12.6
Dividend Score3.30.00.00.00.0
Ownership Score2.05.01.01.00.0
Earnings & Valuation Score0.60.60.61.93.1
Analyst Ratings
Consensus RecommendationHoldBuyHoldHoldN/A
Consensus Price Target$24.80$36.33$5.72$30.50N/A
% Upside from Price Target-3.39% downside-17.42% downside42.97% upside28.37% upsideN/A
Trade Information
Market Cap$1.03 billion$1.23 billion$833.37 million$1.25 billion$67.40 million
Beta0.45N/A1.541.584.52
Average Volume179,13171,7156,162,549600,982N/A
Sales & Book Value
Annual Revenue$828 millionN/A$2.91 billion$392.76 million$15.96 million
Price / Sales1.25N/A0.323.180.00
Cashflow$2.26 per shareN/A$5.48 per share$2.49 per shareN/A
Price / Cash11.38N/A0.739.55N/A
Book Value$5.34 per share$9.29 per share($3.82) per share$11.35 per shareN/A
Price / Book4.81N/A-1.052.09NaN
Profitability
Net Income$54.71 million$-255,130,000.00$-422,640,000.00$113.06 millionN/A
EPS$1.53($13.98)$2.38$2.10$0.07
Trailing P/E Ratio28.52N/AN/A10.959.11
Forward P/E Ratio21.39N/A1.7514.310.00
P/E Growth$16.83N/AN/AN/AN/A
Net Margins4.48%N/A-9.09%28.90%N/A
Return on Equity (ROE)24.23%N/A-91.00%20.31%N/A
Return on Assets (ROA)6.56%N/A6.73%10.28%N/A
Dividend
Annual Payout$0.48N/AN/AN/AN/A
Dividend Yield1.87%N/AN/AN/AN/A
Three-Year Dividend Growth6.27%N/AN/AN/AN/A
Payout Ratio31.37%N/AN/AN/AN/A
Years of Consecutive Dividend Growth2 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.79%0.22%N/A0.62%N/A
Current Ratio2.72%57.22%2.03%3.31%N/A
Quick Ratio1.62%57.22%1.79%3.16%N/A
Ownership Information
Institutional Ownership Percentage50.66%74.90%82.32%92.86%0.08%
Insider Ownership Percentage50.05%39.80%2.30%7.86%N/A
Miscellaneous
Employees1,600123,172448N/A
Shares Outstanding40.45 million28.97 million229.71 million52.54 million105.64 million
Next Earnings Date8/25/2020 (Estimated)8/11/2020 (Estimated)8/3/2020 (Estimated)8/4/2020 (Estimated)N/A
OptionableOptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.